MFG
DXCM icon

Menard Financial Group’s DexCom DXCM Stock Holding History

Menard Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,948
Closed -$505K – 94
2022
Q1 		$505K Buy
3,948
+1,180
+43% +$129K 0.5% 59
2021
Q4 		$372K Sell
2,768
-236
-8% -$33.9K 0.3% 95
2021
Q3 		$411K Buy
3,004
+572
+24% +$72.1K 0.36% 87
2021
Q2 		$260K Buy
+2,432
New +$234K 0.25% 120
2020
Q4 		– Sell
-2,428
Closed -$250K – 144
2020
Q3 		$250K Buy
+2,428
New +$254K 0.29% 113

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Menard Financial Group's DXCM Position: Q2 2022 in Review

Menard Financial Group sold out of DexCom (DXCM) in Q2 2022, closing a stake of 3,948 shares — an estimated $505K sold.

Menard Financial Group first reported a position in DXCM in Q3 2020 and held it in 5 quarters. The position peaked at $505K in Q1 2022. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Menard Financial Group reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Menard Financial Group sold 3,948 DexCom shares in Q2 2022, an estimated $505K.
  • Menard Financial Group first reported a position in DexCom in Q3 2020 and held it in 5 quarters.
  • Menard Financial Group's DexCom position peaked at $505K in Q1 2022.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Menard Financial Group's 13F filing for Q2 2022, filed 15 Aug 2022.